Tanaseanu C - Search Results

1

Plasma markers of endothelial dysfunction in type 2 diabetics.

Moldoveanu E, Tanaseanu C, Tanaseanu S, Kosaka T, Manea G, Marta DS, Popescu LM. Moldoveanu E, et al. Among authors: tanaseanu c, tanaseanu s. Eur J Intern Med. 2006 Jan;17(1):38-42. doi: 10.1016/j.ejim.2005.09.015. Eur J Intern Med. 2006. PMID: 16378884

2

The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable angina.

Tanaseanu C, Moldoveanu E, Kosaka T, Tanaseanu S, Neagu M, Popescu LM. Tanaseanu C, et al. Among authors: tanaseanu s. Eur J Intern Med. 2004 Aug;15(5):291-297. doi: 10.1016/j.ejim.2004.06.002. Eur J Intern Med. 2004. PMID: 15450986

3

Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus.

Tanaseanu C, Tudor S, Tamsulea I, Marta D, Manea G, Moldoveanu E. Tanaseanu C, et al. Eur J Med Res. 2007 Apr 26;12(4):145-51. Eur J Med Res. 2007. PMID: 17509958

4

Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.

Serban M, Tanaseanu C, Kosaka T, Vidulescu C, Stoian I, Marta DS, Tanaseanu S, Moldoveanu E. Serban M, et al. Among authors: tanaseanu c, tanaseanu s. J Cell Mol Med. 2002 Oct-Dec;6(4):643-7. doi: 10.1111/j.1582-4934.2002.tb00462.x. J Cell Mol Med. 2002. PMID: 12611648 Free PMC article.

5

Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results).

Tănăseanu C, Moldoveanu E, Kosaka T, Neagu M, Tănăseanu S, Popescu M, Tamşulea I, Urban A. Tănăseanu C, et al. Among authors: tanaseanu s. Rom J Intern Med. 2003;41(2):145-52. Rom J Intern Med. 2003. PMID: 15526499

6

Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction--a distinct clinical subset.

Tănăseanu C, Moldoveanu E, Tănăseanu S, Popescu M, Dumitraşcu A, Tamşulea I, Urban A, Grecu V, Neagu M, Manea G, Marta D. Tănăseanu C, et al. Among authors: tanaseanu s. Rom J Intern Med. 2004;42(3):545-56. Rom J Intern Med. 2004. PMID: 16370053

7

Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.

Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C. Moldoveanu E, et al. Among authors: tanaseanu c, tanaseanu gr. Clin Biochem. 2008 Dec;41(18):1429-33. doi: 10.1016/j.clinbiochem.2008.09.109. Epub 2008 Oct 7. Clin Biochem. 2008. PMID: 18930040

8

The antiphospholipid antibodies.

Tanaseanu C, Moldoveanu E, Tanaseanu S, Popescu LM. Tanaseanu C, et al. Among authors: tanaseanu s. Haematologia (Budap). 2002;31(4):287-302. doi: 10.1163/15685590160141314. Haematologia (Budap). 2002. PMID: 12038512 Review.

9

Clinical particularities in a Romanian series of Behcet's disease patients.

Tănăseanu S, Tănăseanu C, Pompilian V, Badea C. Tănăseanu S, et al. Among authors: tanaseanu c. Rom J Intern Med. 2003;41(1):41-51. Rom J Intern Med. 2003. PMID: 15529584

10

Limited Wegener's disease presenting as pharyngolaryngeal tumor.

Tănăseanu S, Pompilian V, Tănăseanu C, Badea C, Stăniceanu F, Zurac S, Popescu C, Bacalbaşa A. Tănăseanu S, et al. Among authors: tanaseanu c. Rom J Intern Med. 2003;41(1):95-8. Rom J Intern Med. 2003. PMID: 15529590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page